Pancreatic cancer surgery showdown: which technique saves more lives?

NCT ID NCT07414004

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked back at over 2,400 pancreatic cancer patients who had surgery with vein reconstruction. It compared those who had open surgery to those who had minimally invasive surgery (like laparoscopy or robot-assisted). The goal was to see which approach leads to fewer complications like blood clots and better long-term survival. The results could help doctors decide the best surgical method for these complex cases.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
surgical procedure (open vs. minimally invasive pancreatic surgery with vein resection and reconstruction)
What this could lead to
If this study finds clear advantages for one approach, it could guide surgeons in choosing the best technique for pancreatic cancer patients needing vein reconstruction.
What could go wrong
This is a retrospective study, not a controlled trial, so results may be influenced by patient selection and other factors. It cannot prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • the First Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, Shaanxi, 710061, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.